GLA
KURA icon

Great Lakes Advisors’s Kura Oncology KURA Stock Holding History

Great Lakes Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Sell
259,857
-79,742
-23% -$752K 0.02% 359
2026
Q1 		$2.76M Sell
339,599
-50,632
-13% -$435K 0.02% 358
2025
Q4 		$4.05M Buy
+390,231
New +$4.09M 0.03% 282

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Great Lakes Advisors's KURA Position: Q2 2026 in Review

Great Lakes Advisors reduced its Kura Oncology (KURA) stake by 23% in Q2 2026, selling an estimated $752K and leaving 259,857 shares worth $2.85M. The position accounts for 0.02% of the portfolio, ranked #359.

Great Lakes Advisors first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.05M in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Great Lakes Advisors held 259,857 shares of Kura Oncology worth $2.85M as of Q2 2026.
  • Great Lakes Advisors sold 79,742 Kura Oncology shares in Q2 2026, an estimated $752K.
  • Kura Oncology made up 0.02% of Great Lakes Advisors's portfolio in Q2 2026, its #359 holding.
  • Great Lakes Advisors first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • Great Lakes Advisors's Kura Oncology position peaked at $4.05M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.